EVIDENCE LIBRARY

ECT Seizure-Quality Study Found That Benzodiazepine Associations Depended on the Rating Endpoint

Seizure duration, combined EEG quality and treatment benefit are distinct measurements.

Seizure duration, combined EEG quality and treatment benefit are distinct measurements.

What the source reports

The exploratory study examined 250 bilateral ECT sessions in forty-seven people. Benzodiazepine use appeared among predictors for one seizure-adequacy measure, while oxygenation, hyperventilation and intervals between sessions also mattered. The analysis used repeated-measure methods.

Limits and uncertainty

The study was not a randomized medication-withdrawal trial. Multiple testing was uncorrected, and the authors noted limits of applying a quality scale outside its original validation setting. A seizure-quality association does not establish worsened clinical response.

Application to expert review

For interpreting an ECT course, obtain the particular EEG endpoint, anesthesia regimen, stimulus and medication timing. Do not infer failed treatment solely from benzodiazepine use or a shorter seizure. The paper generates hypotheses about procedural factors while leaving clinical benefit and causation to separate evidence.

Source and related reading

Source: Publication PMC8231613. Applications to expert review are interpretive analysis.

Related reading: Remimazolam Anxiety Dose-Finding Study Used a Specific Parent-Separation Endpoint.